LINFOMAS Y TRASPLANTES
![Foto de LINFOMAS Y TRASPLANTES](/img/grupo.png)
![Foto de Stanford University](/img/noimage_org.png)
Stanford University
Stanford, Estados UnidosStanford University-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2018
-
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
The Lancet Oncology, Vol. 19, Núm. 9, pp. 1192-1204